In This Article:
Madison Mills goes over some of the top stories on this segment of Market Minute.
eToro (ETOR) is skyrocketing after making its debut on the Nasdaq Composite (^IXIC).
Exelixis (EXEL) is soaring after the company beat first quarter estimates and boosted its full-year revenue forecast.
Septerna (SEPN) struck a deal with Novo Nordisk (NVO) for $2.2 billion for obesity medications.
Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
It's time for Yahoo! Finance's market minute. U.S. stocks looking for footing after the S&P 500 erased its year-to-date losses. Meantime, eToro making its public debut on the Nasdaq. The trading platform opening trade at $69.69. That's above the IPO price of $52. The company making its debut after delaying its IPO plans following the president's tariff announcements in April. Exelixis shares rising as the company boosts its revenue forecast for the year. The drug maker also beating earnings and revenue estimates for the first quarter. Cytokinetics inking a $2.2 billion deal with Novo Nordisk. The two companies to collaborate on oral small molecule medicines for obesity. The deal includes more than $200 million in upfront and near-term milestone payments to Cytokinetics. That's your Yahoo! Finance market minute. For more on what's trending on Yahoo! Finance, you can scan the QR code below to track the best and worst performing stocks.